Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Ibrutinib's Cardiotoxicity-An Opportunity for Postmarketing Regulation.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Ibrutinib's Cardiotoxicity-An Opportunity for Postmarketing Regulation.
Ibrutinib's Cardiotoxicity-An Opportunity for Postmarketing Regulation. JAMA Oncol. 2021 02 01; 7(2):177-178.
View in:
PubMed
subject areas
Adenine
Cardiotoxicity
Humans
Piperidines
authors with profiles
Mark J. Ratain